Importantly, in these patients, anemia, leukocytosis, and thrombocythemia are ascribed to their chronic inflammatory disease or cancer and, accordingly, they are not normally screened for JAK2V617F, CALR, or MPL mutations. The gene discussed is CALR; the disease is cancer.